CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Rodman & Renshaw 11th Annual Healthcare Conference at 12:05 p.m. EDT on September 9, 2009, at the New York Palace Hotel in New York City.
